$Pfizer(PFE.US)$
PFE us at resistance, 30.70
Earnings soon, stars aligned
above 50 EMA
When PFE turns, it will move hard and fast. a lot of pressure has been built up over the 1.5-year drop.

$Pfizer(PFE.US)$ im so salty why did I sell why did options stay cheap till I sold then blew up

$Pfizer(PFE.US)$ 1000 percent id be up right now 40 cents up made 100 percent moves a extra 40 could be 1000 wtf

$Sangamo Therapeutics(SGMO.US)$ stock is up after the company announced a successful late-stage trial.
This treatment for patients with hemophilia A appears to have the efficacy and safety metrics in place to warrant a potential approval.
Notably, Sangamo’s candidate is being developed alongside $Pfizer(PFE.US)$ , adding a layer of clout to the R&D behind the prospective treatment.

$Pfizer(PFE.US)$ I remember when this thing would get a couple day spike coming in now it pops then drops right away it seems every time

$Pfizer(PFE.US)$
Sneaking on the radar on a red day.

Follow Our Official Telegram Channel tynkrlab
US stock futures edged higher as the recent downturn in chip stocks started to stabilize, boosting investor sentiment. The market is on edge, anticipating more earnings reports to gauge the health of various sectors.
Market Performance and Key Drivers
1. $Dow Jones Industrial Average(.DJI.US)$ and $S&P 500 Index(.SPX.US)$: The $Dow Jones Industrial Average(.DJI.US)$ closed down 1.29%, driven by ...

$Pfizer(PFE.US)$ this is the only healthcare share rise today . what’s happening to others

A double beat in its latest quarter made Johnson & Johnson $Johnson & Johnson(JNJ.US)$ stock a popular item on Wednesday. The encouraging (if not spectacular) results pushed the storied healthcare company's share price up by almost 4%, which contrasted positively with the 1.4% slide of the S&P 500 index on the day.
Solid growth, particularly in the No. 1 category
Johnson & Johnson revealed that its second-quarter sales came in at slightly over $22.4 bi...